|
⚲
|
| Private Equity Partners 2002 LP | |
|---|---|
| Firm |
Goldman Sachs Asset Management LP
✚
|
| Fund # | 805-8416946461 |
| CIK # | |
| Sale | |
| Fund | Other Private Fund |
| Phone | |
| Address | |
| Source | [IAPD] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | GSAM Gen-Par LLC, Access General Partners LLC |
| Custodian | State Street Bank & Trust Company |
| Auditor | PricewaterhouseCoopers |
| Marketer | Goldman Sachs & Co LLC, Goldman Sachs & Co |
| Broker | |
| Jurisdiction |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Cancer Targeting Systems, Inc.
✚
|
0.0 | |
|
ATeams, Inc.
✚
|
0.0 | |
|
ATS 218, a series of SAX Capital Series Fund III, LP
✚
|
0.0 | |
|
AU Fund I, a series of 5 Eyes Ventures, LP
✚
|
0.0 | |
|
AU Fund I, a series of Matt Bilotti AL Funds, LP
✚
|
0.0 | |
|
AU Fund I, a series of Ride Wave Ventures, LP
✚
|
0.0 | |
|
SAB IV Financial Industries Partnership L.P.
✚
|
0.0 | |
|
Diameter Credit (BDC) Access LP
✚
|
0.0 | |
|
Diamondback Acquisition, Inc.
✚
|
0.0 | |
|
Canamed, Inc.
✚
|
0.0 |